Barclays analyst Charles Pitman CFA reiterated a Buy rating on UCB SA (0NZT – Research Report) today and set a price target of €240.00. The ...

United Community Banks has shown improvement in deposits, loans, and income, leading to an upgrade from 'sell' to a soft ...

In a report released on February 27, David Evans from Kepler Capital maintained a Hold rating on UCB SA (0NZT – Research Report), with a price ...

United Community Banks, Inc. ( NYSE:UCB ) will pay a dividend of $0.24 on the 4th of April. This means that the ...

UCB’s Bimzelx is firmly on physicians’ radars ... The market intelligence company found half of the physicians had trialed Bimzelx in PsA. Spherix compared the level of activity favorably ...

Based in Greenville, United Community Banks (UCB) is in the Finance sector, and so far this year, shares have seen a price change of 6.99%. The bank holding company is paying out a dividend of $0. ...

UCB has a 52 week low of $110.35 and a 52 week high of $200.00. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.78 and a current ratio of 1.19. 10 Stocks to Sell NOW!

Can partnering ensure future success for pharma? UCB is very receptive to outside engagement. There is a real understanding within the company that being internally focussed and concentrating ...

The drug is the first non-cannabinoid option for patients with LGS and an alternative to Jazz Pharma's Epidyolex (cannabidiol) and clobazam, which has been available on the NHS since early 2020, but ...

Navitas Credit Corp. appointed Jason Durgin as senior vice president of sales. Durgin will oversee the company’s Specialty ...

Program delivers evidence based solution to get better outcomes for rare disease patients through Peoplecare's Wellspace digital platform.